Femasys share price today

(FEMY)

Femasys share price is $1.09 & ₹92.62 as on 21 Dec 2024, 2.30 'hrs' IST

$1.09

▲

-0.01

(-0.91%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Femasys share price in Dollar and Rupees. Guide to invest in Femasys from India. Also see the sentimental analysis on Indian investors investing in Femasys. Get details on the Indian mutual funds that are investing in Femasys. Get Analyst recommendations and forecasts along with all the Femasys's financials.

Femasys share price movements

Today's Low: $1.09
Today's High: $1.13
$1.09
0.0%
Downside
Day's Volatility :3.11%
Upside
3.11%
52 Weeks Low: $0.73
52 Weeks High: $2.40
$1.09
32.66%
Downside
52 Weeks Volatility :69.42%
Upside
54.58%

Femasys Returns

Period	Femasys Inc	Index (Russel 2000)
3 Months	-2.68%	0.0%
6 Months	-6.84%	0.0%
1 Year	17.83%	0.0%
3 Years	-76.2%	-19.7%

Femasys Key Statistics

in dollars & INR

Previous Close	$1.1
Open	$1.1
Today's High	$1.125
Today's Low	$1.09
Market Capitalization	$25.2M
Today's Volume	$77.2K
52 Week High	$2.4
52 Week Low	$0.734
Revenue TTM	$950.1K
EBITDA	$-16.1M
Earnings Per Share (EPS)	$-0.81
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-138.37%

How to invest in Femasys from India?

It is very easy for Indian residents to invest directly in Femasys from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Femasys stock in both Indian Rupees (INR) and US Dollars (USD). Search for Femasys or FEMY on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Femasys or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Femasys shares which would translate to 0.780 fractional shares of Femasys as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Femasys, in just a few clicks!

Returns in Femasys for Indian investors in Rupees

Investment Value

₹1,00,000

Femasys investment value today

Current value as on today

₹1,19,400

Returns

₹19,400

(+19.4%)

Returns from Femasys Stock

₹17,204 (+17.2%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Femasys

-7%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Femasys on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -7% less investors are searching Femasys in the last 30 days versus the previous period.

Global Institutional Holdings in Femasys

CM Management, LLC
1.86%
Clear Creek Investment Mgmt LLC
1.34%
Geode Capital Management, LLC
0.90%
Vanguard Group Inc
0.84%
Northern Trust Corp
0.39%
State Street Corp
0.25%

Analyst Recommendation on Femasys

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Femasys(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Femasys

What analysts predicted

Upside of 656.88%

Current:

$1.09

Target:

$8.25

Insights on Femasys

Price Movement
In the last 7 days, FEMY stock has moved down by -8.4%
Increasing Revenue
Revenue is up for the last 2 quarters, 221.48K → 554.90K (in $), with an average increase of 60.1% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -3.59M → -5.40M (in $), with an average decrease of 22.8% per quarter
FEMY vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 57.3% return, outperforming this stock by 34.7%
FEMY vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 50.7% return, outperforming this stock by 124.2%
Price to Sales
ForFEMY every $1 of sales, investors are willing to pay $23.2, whereas for Intuitive Surgical, Inc., the investors are paying $23.6 for every $1 of sales.

Femasys Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$929.1K	-
Net Income	$-11.3M	-
Net Profit Margin	-1.2K%	-

	FY20	Y/Y Change
Revenue	$1.0M	↑ 11.72%
Net Income	$-6.9M	↓ 38.65%
Net Profit Margin	-666.24%	↑ 547.02%

	FY21	Y/Y Change
Revenue	$1.2M	↑ 13.66%
Net Income	$-7.5M	↑ 9.01%
Net Profit Margin	-638.97%	↑ 27.27%

	FY22	Y/Y Change
Revenue	$1.2M	↑ 2.25%
Net Income	$-11.4M	↑ 51.16%
Net Profit Margin	-944.62%	↓ 305.65%

	FY23	Y/Y Change
Revenue	$1.1M	↓ 11.13%
Net Income	$-14.2M	↑ 25.04%
Net Profit Margin	-1.3K%	↓ 384.44%

	Q2 FY23	Q/Q Change
Revenue	$320.5K	↑ 9.02%
Net Income	$-2.9M	↑ 1.44%
Net Profit Margin	-902.77%	↑ 67.52%

	Q3 FY23	Q/Q Change
Revenue	$244.4K	↓ 23.76%
Net Income	$-4.0M	↑ 38.13%
Net Profit Margin	-1.6K%	↓ 732.89%

	Q4 FY23	Q/Q Change
Revenue	$213.1K	↓ 12.79%
Net Income	$-4.4M	↑ 10.35%
Net Profit Margin	-2.1K%	↓ 433.9%

	Q1 FY24	Q/Q Change
Revenue	$271.1K	↑ 27.23%
Net Income	$-3.6M	↓ 18.39%
Net Profit Margin	-1.3K%	↑ 742.01%

	Q2 FY24	Q/Q Change
Revenue	$221.5K	↓ 18.31%
Net Income	$-4.7M	↑ 30.14%
Net Profit Margin	-2.1K%	↓ 787.53%

	Q3 FY24	Q/Q Change
Revenue	$554.9K	↑ 150.54%
Net Income	$-5.4M	↑ 15.46%
Net Profit Margin	-974.73%	↑ 1140.35%

	FY19	Y/Y Change
Profit	$705.4K	-

	FY20	Y/Y Change
Profit	$731.4K	↑ 3.69%

	FY21	Y/Y Change
Profit	$809.3K	↑ 10.65%

	FY22	Y/Y Change
Profit	$764.3K	↓ 5.56%

	FY23	Y/Y Change
Profit	$691.9K	↓ 9.47%

	Q2 FY23	Q/Q Change
Profit	$210.0K	↑ 11.21%

	Q3 FY23	Q/Q Change
Profit	$158.2K	↓ 24.69%

	Q4 FY23	Q/Q Change
Profit	$-107.3K	↓ 167.85%

	Q1 FY24	Q/Q Change
Profit	$-41.3K	↓ 61.53%

	Q2 FY24	Q/Q Change
Profit	$148.4K	↓ 459.36%

	Q3 FY24	Q/Q Change
Profit	$364.1K	↑ 145.4%

	FY19	Y/Y Change
Operating Cash Flow	$-11.0M	-
Investing Cash Flow	$12.3M	-
Financing Cash Flow	$-127.8K	-

	FY20	Y/Y Change
Operating Cash Flow	$-4.9M	↓ 55.18%
Investing Cash Flow	$968.3K	↓ 92.14%
Financing Cash Flow	$871.6K	↓ 782.14%

	FY21	Y/Y Change
Operating Cash Flow	$-7.9M	↑ 60.77%
Investing Cash Flow	$-306.9K	↓ 131.69%
Financing Cash Flow	$29.7M	↑ 3307.16%

	FY22	Y/Y Change
Operating Cash Flow	$-10.7M	↑ 35.32%
Investing Cash Flow	$-407.5K	↑ 32.79%
Financing Cash Flow	$-681.6K	↓ 102.3%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-2.7M	↑ 3.53%
Investing Cash Flow	$-62.9K	↑ 0.0%
Financing Cash Flow	$3.3M	↓ 2423.9%

Femasys Technicals Summary

Sell

Neutral

Buy

Femasys is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Femasys Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Femasys Inc	3.81%	-6.84%	17.83%	-76.2%	-90.92%
Intuitive Surgical, Inc.	-4.28%	22.23%	55.44%	44.1%	162.74%
Resmed Inc.	-2.67%	30.23%	36.84%	-8.33%	51.42%
Becton, Dickinson And Company	1.64%	-3.49%	-6.42%	-8.53%	-16.6%
West Pharmaceutical Services Inc	4.68%	0.12%	-7.26%	-27.93%	119.86%
Alcon Ag	-1.43%	-5.74%	9.38%	-2.15%	48.55%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Femasys Inc	NA	NA	NA	-0.8	-1.38	-0.6	NA	0.85
Intuitive Surgical, Inc.	84.09	84.09	3.89	6.85	0.16	0.08	NA	43.75
Resmed Inc.	30.67	30.67	1.75	7.71	0.24	0.13	0.01	35.39
Becton, Dickinson And Company	38.13	38.13	1.02	13.11	0.06	0.03	0.02	89.47
West Pharmaceutical Services Inc	48.52	48.52	6.07	6.66	0.18	0.1	0.0	37.96
Alcon Ag	35.97	35.97	3.05	3.03	0.06	0.03	0.0	43.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Femasys Inc	Buy	$25.2M	-90.92%	NA	0.0%
Intuitive Surgical, Inc.	Buy	$186.6B	162.74%	84.09	28.51%
Resmed Inc.	Buy	$34.0B	51.42%	30.67	23.15%
Becton, Dickinson And Company	Buy	$64.7B	-16.6%	38.13	7.13%
West Pharmaceutical Services Inc	Buy	$23.7B	119.86%	48.52	17.37%
Alcon Ag	Buy	$41.6B	48.55%	35.97	11.89%

About Femasys

our experienced management team has over 200 years of collective industry experience with extensive focus in medical devices. the pioneering and collaborative efforts of the management team have created an organization that strives for integrity in all actions, innovation in development activities, excellence in operations, and the highest quality products. the team is complemented by world-class medical advisors. our products have been organically conceived, researched and developed by the company and all manufacturing activities are conducted to ensure compliance with the u.s. food and drug administration (fda) per the requirements of 21 cfr 820, as well as iso 13485. femasys has achieved significant milestones to date, including numerous issued patents and filings, recruitment of a team of experts, clearance of multiple regulatory filings by the u.s. food and drug administration (fda), european union, canada, and japan with other select countries in process. making a difference in t

Organization	Femasys
Employees	32
CEO	Ms. Kathy Lee-Sepsick M.B.A.
Industry	Miscellaneous

Management People of Femasys

Name	Title
Ms. Kathy Lee-Sepsick M.B.A.	Founder, President, CEO & Director
Mr. Dov Elefant	Chief Financial Officer
Mr. Daniel Scott Currie	COO, Senior VP & Secretary
Ms. Mary An Merchant J.D., Ph.D.	Vice President of Counsel & Intellectual Property
Ms. Sue Owens	Vice President of Sales
Ms. Naomi Phaneuf	Vice President of Marketing
Dr. Jeffrey Marcus M.D., M.S.	Chief Medical Advisor
Ms. Christine Thomas	Senior VP of Regulatory & Clinical Affairs
Dr. James H. Liu M.D.	Chief Medical Officer
Mr. Richard Spector	Chief Commercial Officer

Important FAQs about investing in Femasys from India :

What is Femasys share price today?

Femasys share price today stands at $1.09, Open: $1.10 ; Previous Close: $1.10 ; High: $1.13 ; Low: $1.09 ; 52 Week High: $2.40 ; 52 Week Low: $0.73. The stock opens at $1.10, after a previous close of $1.10. The stock reached a daily high of $1.13 and a low of $1.09, with a 52-week high of $2.40 and a 52-week low of $0.73.

Can Indians buy Femasys shares?

Yes, Indians can invest in the Femasys (FEMY) from India.

With INDmoney, you can buy Femasys at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Femasys at zero transaction cost.

How can I buy Femasys shares from India?

It is very easy to buy Femasys from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Femasys be purchased?

Yes, you can buy fractional shares of Femasys with INDmoney app.

What are the documents required to start investing in Femasys stocks?

To start investing in Femasys, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.